AI Summary
We reviewed 132 live results for subsidised insulin glargine lantus dispensing and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Insulin and Public Health.
We reviewed 132 live results for subsidised insulin glargine lantus dispensing and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Insulin and Public Health.
Source: Public Healthcare Institutions
Description
Provision of Lantus (insulin glargine) through public healthcare pharmacies and outpatient clinics. As an SDL-listed drug, it is available to eligible patients at subsidized rates across polyclinics and restructured hospitals.
Best for
Subsidized healthcare seekers, Polyclinic patients, Long Term treatment plans and Government Subsidized medication
Rating
Source: Sanofi
Description
Lantus adalah insulin glargine analog kerja panjang yang memberikan pelepasan insulin stabil selama 24 jam. Produk ini merupakan standar emas global untuk terapi insulin basal.
Best for
Insulin kerja panjang, Kontrol basal harian, Diabetes tipe 1 dan 2 and Standar global
Rating
Source: Sanofi-Aventis Singapore Pte. Ltd.
Description
Insulin glargine 100 units/mL solution for injection in a 10mL vial. This basal insulin offers consistent glucose-lowering effects over a 24-hour period, helping patients maintain stable glycemic control. Use typically involves withdrawal via a separate syringe.
Best for
Syringe Based administration, Multi Dose usage, Long Acting blood sugar control and Hospital and clinical use
Rating
| Compare | Subsidised Insulin Glargine (Lantus) Dispensing | Lantus | Lantus Vial |
|---|---|---|---|
| Source | Public Healthcare Institutions | Sanofi | Sanofi-Aventis Singapore Pte. Ltd. |
| Description | Provision of Lantus (insulin glargine) through public healthcare pharmacies and outpatient clinics. As an SDL-listed drug, it is available to eligible patients at subsidized rates across polyclinics and restructured hospitals. | Lantus adalah insulin glargine analog kerja panjang yang memberikan pelepasan insulin stabil selama 24 jam. Produk ini merupakan standar emas global untuk terapi insulin basal. | Insulin glargine 100 units/mL solution for injection in a 10mL vial. This basal insulin offers consistent glucose-lowering effects over a 24-hour period, helping patients maintain stable glycemic control. Use typically involves withdrawal via a separate syringe. |
| Best for | Subsidized healthcare seekers, Polyclinic patients, Long Term treatment plans and Government Subsidized medication | Insulin kerja panjang, Kontrol basal harian, Diabetes tipe 1 dan 2 and Standar global | Syringe Based administration, Multi Dose usage, Long Acting blood sugar control and Hospital and clinical use |
| Action | |||
| Rating |
If you want the most balanced option to start with, I recommend:
"Subsidised Insulin Glargine (Lantus) Dispensing from Public Healthcare Institutions."
I picked this because The most cost-effective option for Singaporean citizens and PRs to access Lantus through government-subsidized healthcare channels.
Note: TopFind provides comparison information for general research purposes only.